findmyKOL

Hisham Hafez, MD

Basic profile

Dartmouth College

ORCIDNone on fileNPI
RegionNashua, NH · NortheastSpecialtyPsychiatryFocusPsychiatry
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2015Online presenceNot yet checkedPayments2021 onwardNIH funding2009–2012Why? →

Hisham Hafez is a Psychiatry physician affiliated with Dartmouth College. OpenAlex indexes 11 publications with 878 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
11publications

Distinct works indexed by OpenAlex.

878citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2009–2012

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

30 Temple Street
Suite 105
Nashua, NH 03060

Telephone

603-880-9880

Registry record last updated 6 Apr 2015.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    95.6%
    Benzodiazepine25.1%
    Lorazepam42%Clonazepam29%Alprazolam14%Temazepam7%Diazepam6%Alprazolam Er3%
    Part D<11 patients
    SSRI13.6%
    Trazodone Hcl24%Fluoxetine Hcl22%Sertraline Hcl19%Escitalopram Oxalate13%Citalopram Hbr12%Paroxetine Hcl10%
    Part D<11 patients

    + 22 more classes in this area

  • Cardiovascular

    2.6%
    alpha-Adrenergic Blocker1.1%
    Prazosin Hcl100%
    Part D<11 patients
    Beta blocker1%
    Propranolol Hcl Er64%Propranolol Hcl36%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    0.9%
    Proton pump inhibitor0.5%
    Omeprazole100%
    Part D<11 patients
    Sulfonylurea0.4%
    Glipizide Er100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20092012 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”